# TriRx Segre – FDA Inspection, Jan 13, 2022

Source: https://www.keypedia.com/records/fda_inspections/trirx-segre/6330b659-b31d-4829-a4ed-fdc480b71aff
Source feed: FDA_Inspections

> FDA inspection 1243433 of TriRx Segre, January 13, 2022. Classification: Voluntary Action Indicated (VAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1243433
- Company Name: TriRx Segre
- Inspection Date: 2022-01-13
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Monitoring of Marketed Animal Drugs, Feed, and Devices
- Product Type: Veterinary
- Center: Animal Drugs & Feeds
- Office Name: Center for Veterinary Medicine
- Citation Count: 0

## Related Documents

- [FDA Inspection 1316560 - 2026-04-23](https://www.keypedia.com/records/fda_inspections/trirx-segre/aac32774-1e07-40a5-bb03-19b6f95c524e)
- FDA Inspection 1021437 - 2017-07-07
- [FDA Inspection 789010 - 2012-06-15](https://www.keypedia.com/records/fda_inspections/trirx-segre/dfebd866-9f45-4658-8010-be368c63e031)

Company: https://www.keypedia.com/companies/trirx-segre/b1afa3a7-c8ed-44d5-b6f3-ec86e6af76ba

Office: https://www.keypedia.com/offices/center-for-veterinary-medicine/7e30a309-56e4-4e7a-8b8b-e07674bb07b4
